ResourcesFostering Higher Foreign Contributions to Pharma R&D Through Trade Deals, Deregulation and Aligning Incentives Resources / healnetwork1
ResourcesMandatory Value-Based Payment Programs and Hospital Administrative Costs Resources / healnetwork1
ResourcesProfitability Of Infused Biologics For Hospitals And Physician Practices: Case Study Of Keytruda Resources / healnetwork1
ResourcesAssessing The Value Of Post-Approval Research For U.S. Policy Makers Resources / healnetwork1
ResourcesWhy Do We Hear More About High Drug Prices Than About Hospital Prices? Resources / healnetwork1
ResourcesFormulary-Related Insurance Denials of Single-Source Branded Drugs in the United States Resources / healnetwork1
ResourcesStretching Scarce Authorizing Legislation as Far as Possible: A Legislative History of the 340B Drug Pricing Program Resources / healnetwork1